Armistice Capital, LLC 13D/13G Filings for REXAHN PHARMACEUTICALS INC (REXN)

Armistice Capital, LLC 13D and 13G filings for REXAHN PHARMACEUTICALS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-08-10
5:02 pm
Purchase
2020-07-31 13G REXAHN PHARMACEUTICALS INC
REXN
Armistice Capital, LLC 44,145
1.000%
44,145increase
(New Position)
Filing